SCHEMBL30101299

SCHEMBL30101299

CCCN1CCCCCCC(=O)CC(=O)OCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
ALDH1A1 P00352 5/20 0.32
MAPT P10636 4/20 0.32
POLB P06746 2/20 0.32
ADRA2C P18825 2/20 0.32
HRH1 P35367 2/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
THRB P10828 3/20 0.32
HRH3 Q9Y5N1 2/20 0.32
LMNA P02545 2/20 0.32
HSD17B10 Q99714 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL725118 0.77 POLB (0.40) CYP1A2CYP2D6ALDH1A1POLBCA1
SCHEMBL4246548 0.72 ALDH1A1 (0.37) CYP1A2ALDH1A1MAPTSIGMAR1THRB
Fluoride SCHEMBL1963693 0.71 HRH3 (0.52) CYP1A2ALDH1A1MAPTPOLBSIGMAR1
SCHEMBL16625898 0.70 POLB (0.41) ALDH1A1MAPTPOLBSIGMAR1THRB
SCHEMBL12883403 0.69 CA1 (0.64) ALDH1A1CA1CA9LMNATSHR
SCHEMBL23600074 0.69 HRH3 (0.55) CYP1A2ALDH1A1MAPTPOLBSIGMAR1
SCHEMBL2745438 0.69
SCHEMBL19250122 0.69 HRH3 (0.55) CYP1A2ALDH1A1MAPTPOLBSIGMAR1
SCHEMBL14926143 0.69 HRH3 (0.55) CYP1A2ALDH1A1MAPTPOLBSIGMAR1
SCHEMBL81143 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4358970-A1 COMPOUNDS FOR TREATING GENETIC DISEASES Zikani Therapeutics, Inc. (US) 2024-05-01 EP disclosed
WO-2022251730-A1 COMPOUNDS FOR TREATING GENETIC DISEASES ZIKANI THERAPEUTICS, INC. (US) 2022-12-01 WO disclosed